PRECISION BIOSCIENCES INC
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $34.3M | $68.7M | $48.7M | $25.1M | $115.5M |
| Operating income | -$52.1M | -$26.2M | -$43.7M | -$62.3M | -$39.4M |
| Operating expenses | $86.4M | $94.9M | $92.5M | $87.4M | $154.9M |
| Cash from operations | -$65.8M | -$58.4M | -$84.1M | -$45.8M | -$10.9M |
| Capital expenditure | $85,000 | $250,000 | $2.0M | $3.3M | $5.1M |
| Free cash flow | -$65.9M | -$58.7M | -$86.1M | -$49.1M | -$15.9M |
| Impairments | $36,000 | $0 | $0 | $10.8M | — |
| Total assets | $154.4M | $136.4M | $159.8M | $238.2M | $211.5M |
| Total liabilities | $62.2M | $80.0M | $140.9M | $177.7M | $120.3M |
Shares outstanding 25.8M · Free float 39.3%
Annual filing data through FY ended December 31, 2025; float as of July 13, 2026.